Fortrea Holdings Inc. (FTRE) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Fortrea Holdings Inc. (FTRE:NASDAQ), powered by AI.

Current Price
$15.98
P/E Ratio
-1.5
Market Cap
1.5B
Sector
Healthcare
What is the Fortrea Holdings Inc. stock price forecast?

Fortrea Holdings Inc. is currently trading at $15.98. View real-time AI analysis on Alpha Lenz.

What is Fortrea Holdings Inc. insider trading activity?

View the latest insider trading data for Fortrea Holdings Inc. on Alpha Lenz.

What is Fortrea Holdings Inc.'s P/E ratio?

Fortrea Holdings Inc.'s P/E ratio is -1.5.

Fortrea Holdings Inc.

NASDAQ · FTRE
$15.98-0.65(-3.91%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Fortrea Holdings Inc.'s future dividend policy...
Alpha Chat Insight

Fortrea Holdings Inc. trades at a P/E of -1.5 (undervalued) with modest ROE of -102.4%.

Ask for details

Company Overview

Fortrea Holdings Inc. is a key player in the clinical research industry, focusing on providing contract research services globally. The company specializes in organizing and managing clinical trials for pharmaceutical and biotechnology firms, aiding them in navigating the complex regulatory and competitive landscape of drug development and approval. Fortrea leverages its expertise to ensure that trials are conducted efficiently and in compliance with stringent international health standards. Its services are crucial in bringing new pharmaceuticals and therapies to market, impacting a variety of sectors, including oncology, cardiology, and neurology. Fortrea’s comprehensive capabilities in trial execution and data management position it as a vital contributor to the advancement of medical science and healthcare solutions, demonstrating its pivotal role in the pharmaceutical supply chain.

CEOMr. Thomas H. Pike
SectorHealthcare
IndustryBiotechnology
Employees15,500

Company Statistics

FY 2025

Profile

$1.46BMarket Cap
$2.72BRevenue
0.00Shares Out
15,500Employees

Margins

18.50%Gross
2.03%EBITDA
-1.12%Operating
-36.09%Pre-Tax
-36.21%Net

Valuation

-1.48P/E
2.59P/B
0.54EV/Sales
43.39EV/EBITDA
16.51P/FCF

Growth (CAGR)

-4.19%Rev 3Yr
1.09%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-31.33%ROA
-102.41%ROE
-28.33%ROIC

Financial Health

$174.60MCash & Cash Equivalents
$1.98BNet Debt
381.93%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Fortrea Holdings Inc. (ticker: FTRE) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 15,500 employees. Market cap is $1.5B.

The current price is $15.98 with a P/E ratio of -1.48x and P/B of 2.59x.

ROE is -102.41% and operating margin is -1.12%. Annual revenue is $2.7B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Fortrea Holdings Inc. (FTRE) Stock Forecast 2026 $15.98 — Price, Financials & Analyst Targets | Alpha Lenz